Sema4|GeneDx to Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study.  Learn more >>

BRCA1/2 Sequencing and Del/Dup analysis

New York
Approved


Genes

BRCA1, BRCA2

Conditions

  • Ovarian Cancer
  • Breast Cancer

Clinical Utility

  • Verification of a genetic basis for cancer in families indicative/suggestive of hereditary breast and ovarian cancer.
  • Determination of appropriate screening and treatment.
  • Identification of at-risk family members.

Lab Method

  • Deletion/Duplication Analysis
  • Next-Gen Sequencing

Test Code

B362

CPT Codes*

81162x1

ABN Required

No

Turnaround Time**

8-10 days

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs | Fibroblasts (separate charge for cell culture may apply)

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.